ID   ERRFI_RAT               Reviewed;         459 AA.
AC   P05432;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1988, sequence version 1.
DT   24-JUL-2024, entry version 152.
DE   RecName: Full=ERBB receptor feedback inhibitor 1;
DE   AltName: Full=Gene 33 polypeptide;
DE   AltName: Full=Mitogen-inducible gene 6 protein homolog;
DE            Short=MIG-6;
DE   AltName: Full=Receptor-associated late transducer;
DE            Short=RALT;
GN   Name=Errfi1; Synonyms=33, Mig6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=3224831; DOI=10.1016/0378-1119(88)90058-3;
RA   Tindal M.H., Lee K.-L., Isham K.R., Cadilla C., Kenney F.T.;
RT   "Structure of a multihormonally regulated rat gene.";
RL   Gene 71:413-420(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=2780291; DOI=10.1093/nar/17.16.6651;
RA   Chrapkiewicz N.B., Davis C.M., Chu D.T.W., Granner D.K.;
RT   "Rat gene 33: analysis of its structure, messenger RNA and basal promoter
RT   activity.";
RL   Nucleic Acids Res. 17:6651-6667(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Liver;
RX   PubMed=2916834; DOI=10.1016/0003-9861(89)90091-x;
RA   Lee K.-L., Makkinje A., Ch'Ang L.-Y., Kenney F.T.;
RT   "Molecular cloning and analysis of full-length cDNAs cognate to a rat gene
RT   under multihormonal control.";
RL   Arch. Biochem. Biophys. 269:106-113(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, PHOSPHORYLATION, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   ERBB2.
RX   PubMed=11003669; DOI=10.1128/mcb.20.20.7735-7750.2000;
RA   Fiorentino L., Pertica C., Fiorini M., Talora C., Crescenzi M.,
RA   Castellani L., Alema S., Benedetti P., Segatto O.;
RT   "Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a
RT   mitogen-induced signal transducer which binds to the ErbB-2 kinase
RT   domain.";
RL   Mol. Cell. Biol. 20:7735-7750(2000).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH EGFR.
RX   PubMed=17599051; DOI=10.1038/sj.onc.1210590;
RA   Anastasi S., Baietti M.F., Frosi Y., Alema S., Segatto O.;
RT   "The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression
RT   of the EGFR catalytic activity.";
RL   Oncogene 26:7833-7846(2007).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Negative regulator of EGFR signaling in skin morphogenesis.
CC       Acts as a negative regulator for several EGFR family members, including
CC       ERBB2, ERBB3 and ERBB4. Inhibits EGFR catalytic activity by interfering
CC       with its dimerization. Inhibits autophosphorylation of EGFR, ERBB2 and
CC       ERBB4. Important for normal keratinocyte proliferation and
CC       differentiation. Plays a role in modulating the response to steroid
CC       hormones in the uterus. Required for normal response to progesterone in
CC       the uterus and for fertility. Mediates epithelial estrogen responses in
CC       the uterus by regulating ESR1 levels and activation. Important for
CC       regulation of endometrium cell proliferation. Important for normal
CC       prenatal and perinatal lung development (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:11003669, ECO:0000269|PubMed:17599051}.
CC   -!- SUBUNIT: Interacts with EGFR and ERBB2. {ECO:0000269|PubMed:11003669,
CC       ECO:0000269|PubMed:17599051}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic
CC       side {ECO:0000250}. Nucleus {ECO:0000250}. Note=Associated with the
CC       plasma membrane of basal skin keratinocytes. Translocates into the
CC       nucleus of differentiating suprabasal keratinocytes (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05432-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05432-2; Sequence=VSP_011893;
CC   -!- INDUCTION: By cAMP, glucocorticoids, phorbol esters and insulin.
CC   -!- DOMAIN: The EGFR-binding region prevents binding of a cyclin-like
CC       activator to the EGFR kinase domain, and thereby keeps EGFR in an
CC       inactive conformation. Also maintains EGFR in an inactive conformation
CC       by preventing formation of an asymmetric homodimer (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the MIG6 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M23572; AAB08828.1; -; Genomic_DNA.
DR   EMBL; M23570; AAB08828.1; JOINED; Genomic_DNA.
DR   EMBL; M23571; AAB08828.1; JOINED; Genomic_DNA.
DR   EMBL; X07266; CAA30252.1; -; mRNA.
DR   EMBL; BC083845; AAH83845.1; -; mRNA.
DR   PIR; S03116; S03116.
DR   RefSeq; NP_001014093.1; NM_001014071.1. [P05432-1]
DR   RefSeq; XP_008762482.1; XM_008764260.2.
DR   RefSeq; XP_008762483.1; XM_008764261.2.
DR   RefSeq; XP_008762484.1; XM_008764262.2. [P05432-2]
DR   AlphaFoldDB; P05432; -.
DR   SMR; P05432; -.
DR   BioGRID; 260526; 5.
DR   STRING; 10116.ENSRNOP00000072811; -.
DR   iPTMnet; P05432; -.
DR   PhosphoSitePlus; P05432; -.
DR   Ensembl; ENSRNOT00055024361; ENSRNOP00055019906; ENSRNOG00055014174. [P05432-1]
DR   GeneID; 313729; -.
DR   KEGG; rno:313729; -.
DR   UCSC; RGD:1307599; rat. [P05432-1]
DR   AGR; RGD:1307599; -.
DR   CTD; 54206; -.
DR   RGD; 1307599; Errfi1.
DR   VEuPathDB; HostDB:ENSRNOG00000058186; -.
DR   eggNOG; ENOG502QPQW; Eukaryota.
DR   HOGENOM; CLU_604032_0_0_1; -.
DR   InParanoid; P05432; -.
DR   OrthoDB; 5345626at2759; -.
DR   PhylomeDB; P05432; -.
DR   TreeFam; TF335720; -.
DR   PRO; PR:P05432; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000058186; Expressed in liver and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; IDA:RGD.
DR   GO; GO:0031267; F:small GTPase binding; IPI:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0006699; P:bile acid biosynthetic process; ISO:RGD.
DR   GO; GO:0051216; P:cartilage development; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0071474; P:cellular hyperosmotic response; IEP:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; IEP:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0035988; P:chondrocyte proliferation; ISO:RGD.
DR   GO; GO:0007566; P:embryo implantation; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0050673; P:epithelial cell proliferation; ISO:RGD.
DR   GO; GO:0060429; P:epithelium development; ISO:RGD.
DR   GO; GO:0060613; P:fat pad development; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0006006; P:glucose metabolic process; ISO:RGD.
DR   GO; GO:0036022; P:limb joint morphogenesis; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISO:RGD.
DR   GO; GO:0048286; P:lung alveolus development; ISS:UniProtKB.
DR   GO; GO:0060428; P:lung epithelium development; ISS:UniProtKB.
DR   GO; GO:0060426; P:lung vasculature development; ISS:UniProtKB.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; IDA:RGD.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IMP:RGD.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; IMP:RGD.
DR   GO; GO:0007175; P:negative regulation of epidermal growth factor-activated receptor activity; IDA:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IDA:RGD.
DR   GO; GO:0032691; P:negative regulation of interleukin-1 beta production; IMP:RGD.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0031953; P:negative regulation of protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0050847; P:progesterone receptor signaling pathway; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0061469; P:regulation of type B pancreatic cell proliferation; IMP:RGD.
DR   GO; GO:1904565; P:response to 1-oleoyl-sn-glycerol 3-phosphate; ISO:RGD.
DR   GO; GO:0032355; P:response to estradiol; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   GO; GO:0032570; P:response to progesterone; ISO:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0001501; P:skeletal system development; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0043589; P:skin morphogenesis; ISS:UniProtKB.
DR   GO; GO:0001894; P:tissue homeostasis; ISO:RGD.
DR   GO; GO:0035847; P:uterine epithelium development; ISO:RGD.
DR   GO; GO:0060065; P:uterus development; ISO:RGD.
DR   InterPro; IPR015116; Cdc42-bd-like.
DR   InterPro; IPR052112; EGFR_SigReg_Kinase.
DR   InterPro; IPR021619; Mig-6.
DR   PANTHER; PTHR14254:SF5; ERBB RECEPTOR FEEDBACK INHIBITOR 1; 1.
DR   PANTHER; PTHR14254; GENE 33 POLYPEPTIDE; 1.
DR   Pfam; PF09027; GTPase_binding; 1.
DR   Pfam; PF11555; Inhibitor_Mig-6; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane; Cytoplasm; Membrane;
KW   Nucleus; Phosphoprotein; Reference proteome; Tumor suppressor.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM3"
FT   CHAIN           2..459
FT                   /note="ERBB receptor feedback inhibitor 1"
FT                   /id="PRO_0000096489"
FT   REGION          227..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          332..361
FT                   /note="Interaction with EGFR and ERBB2 and regulation of
FT                   EGFR activation"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        323..345
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM3"
FT   MOD_RES         126
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JZ7"
FT   MOD_RES         130
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JZ7"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         271
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM3"
FT   MOD_RES         300
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99JZ7"
FT   MOD_RES         458
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UJM3"
FT   VAR_SEQ         67..142
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2916834"
FT                   /id="VSP_011893"
FT   CONFLICT        18
FT                   /note="G -> K (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        192
FT                   /note="Y -> T (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        302
FT                   /note="E -> L (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        311
FT                   /note="E -> L (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396
FT                   /note="E -> L (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410
FT                   /note="E -> L (in Ref. 3; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   459 AA;  49941 MW;  EBD90F11757AC549 CRC64;
     MSTAGVAAQD IRVPLKTGFL HNGQALGNMK TCWGSRNEFE KNFLNIDPIT MAYNLNSPAP
     EHLTTLGCAS PSAPGSGHFF AERGPSPKSS LPPLVIPPSE SSGQREEDQV LCGFKKLSVN
     GVCASTPPLT PIQSCSSPFP CAAPCDRSSR PLPPLPISED PSLDEADCEV EFLTSADTDF
     LLEDCVPSDF KYDVPGRRSF RGCGQINYAY FDSPTVSVAD LSCASDQNRV VPDPNPPPPQ
     SHRRLRRSHS GPAGSFNKPA IRISSCTHRA SPSSDEDKPE IPPRVPIPPR PAKPDYRRWS
     AEVTSNTYSD EDRPPKVPPR EPLSRSNSRT PSPKSLPSYL NGVMPPTQSF APDPKYVSSK
     ALQRQSSEGS AKAPCILPII ENGKKVSSTH YYLLPERPPY LDKYEKYFRE AEEANPSTQI
     QPLPAACGMV SATDKLASRM KMDVGGHGKR KHLSYVVSP
//
